Heather Turner

CNS pipeline · person

Heather Turner, J.D.

Chief Executive Officer and director of LB Pharmaceuticals since November 2024. Previously President and CEO of Carmot Therapeutics, which she led to a multi-billion-dollar acquisition by Roche, with prior leadership roles at Lyell Immunopharma, Sangamo Therapeutics, and Atara Biotherapeutics.

  • 1 company

Courtesy LB Pharmaceuticals

Current roles

Appears with

People sharing a company with Heather.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.